Key facts
- Convergence Medical’s last known valuation is $30.0M (Jan 2025).
- It has raised $6.7M; the latest was Early Stage VC ($5.0M) in Jan 2025.
- Notable investors include AngelLoop, Avicella Capital, Brisbane Angels, Brisbane Economic Development Agency, UniQuest Extension Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Convergence Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Convergence Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Convergence Medical
Developer of an arthroscopic robot designed to improve illumination and decrease the risk of cartilage damage. The company's robot is integrated with the motors and controller which allows continuous position and status monitoring in the surgical field, enabling doctors to automate procedures and make surgery easy.
- Sector
- Information Technology
- HQ
- Brisbane, Australia
- Founded
- 2022
- Employees
- 9
- Website
- convergenceortho.com/
- Ownership
- Privately Held (backing)
Convergence Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Convergence Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Convergence Medical in its N-PORT filings yet. We sweep new filings monthly.